Drug Shortage Report for DOSTINEX
| Report ID | 66323 |
| Drug Identification Number | 02242471 |
| Brand name | DOSTINEX |
| Common or Proper name | DOSTINEX |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | CABERGOLINE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 8's |
| ATC code | G02CB |
| ATC description | OTHER GYNECOLOGICALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-11-02 |
| Estimated end date | |
| Actual end date | 2018-11-21 |
| Shortage status | Resolved |
| Updated date | 2018-11-22 |
| Company comments | Distributed by Paladin. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-11-22 | English | Compare |
| v6 | 2018-11-21 | French | Compare |
| v5 | 2018-11-21 | English | Compare |
| v4 | 2018-11-19 | French | Compare |
| v3 | 2018-11-19 | English | Compare |
| v2 | 2018-11-06 | French | Compare |
| v1 | 2018-11-06 | English | Compare |
Showing 1 to 7 of 7